The COVID-19 pandemic accelerated the global demand for fast, reliable, and accessible diagnostic tools. Once confined to centralized laboratories, PCR technology is now expected to deliver high-precision results at or near the point of care. Leading this transformation in India is Retro Biotech, a Jaipur-based startup revolutionizing molecular diagnostics through its innovative extraction-free PCR solutions.
Founded in 2023, Retro Biotech is on a mission to simplify and scale gold-standard diagnostics for real world clinical needs. With a sharp focus on infectious diseases, antimicrobial resistance, and oncology, the company aims to make advanced diagnostics as user-friendly as common at-home tests.
Bridging the Accessibility Gap
Retro Biotech’s core innovation lies in its ability to eliminate the labor-intensive extraction step in PCR testing. Traditional PCR workflows require complex sample processing, trained technicians, and cold-chain logistics. In contrast, the company’s platform enables clinicians to directly add unprocessed samples, such as saliva, swabs, or urine, to prefilled, room-temperature-stable PCR strips. This significantly reduces turnaround time and technical dependency.
“Our vision is to make molecular testing as practical as checking blood sugar, without compromising on accuracy”, says Dr Rahul Sharma, Chairman, Retro Biotech.
This approach bridges the longstanding gap between diagnostic sensitivity and operational simplicity. Retro’s extraction-free kits provide labgrade results and are ideal for use in outpatient clinics, emergency rooms, community hospitals, and even field settings where conventional labs are inaccessible.
A Flexible & Scalable Platform
Retro Biotech has built a modular system that supports both low-throughput point-of-care testing and high through put laboratory use. Its diagnostic platform allows providers to run targeted pathogen panels or configure broader assays, depending on the application. Designed to work with widely available PCR machines, it avoid the costly lock-in of proprietary hardware.
Moreover, the company’s reagents are engineered for stability at ambient temperatures, critical for use in regions with unreliable cold chains. Combined with portable devices, the system ensures that quality diagnostics can reach even the most underserved geographies.
Data-Driven Innovation
Retro Biotech follows a rigorous postlaunch feedback loop. Each product rollout is followed by structured surveillance that gathers real-world usage data, customer insights, and technical performance metrics. These findings guide software improvements, protocol updates, and new iterations of the product, ensuring solutions remain responsive to user needs.
Additionally, the company also maintains strategic collaborations with hospitals, public health labs, and international research institutions. These partnerships help validate test performance across diverse patient populations and support the rapid adoption of new assays in response to emerging pathogens.
Our vision is to make molecular testing as practical as checking blood sugar, without compromising on accuracy
Commitment to Quality & Security
In addition to diagnostic innovation, the company places strong emphasis on compliance and patient data protection. All systems are built to meet HIPAA and GDPR standards, with encrypted, access controlled, and audit-logged workflows. Whether integrating into lab information systems or reporting results digitally, data security is never compromised.
Furthermore, the company has also licensed several of its technologies to global manufacturers, reflecting its growing reputation as a homegrown innovator with global potential.
Shaping the Future of Diagnostics
Looking ahead, the company is focused on expanding its role as a global enabler of near-patient diagnostics. Future developments include integration with AI-based result interpretation, cloud-connected platforms for remote monitoring, and regulatory approvals to scale internationally.
By lowering the technical barriers to molecular diagnostics, Retro Biotech is empowering healthcare providers with tools that are fast, affordable, and reliable, no matter where they practice. In doing so, the company is not just meeting market needs but redefining what’s possible in diagnostic care.
.jpg "Transforming Healthcare Through Cutting-Edge Through Cutting-Edge Biotech Solutions")
.jpg "Telawne Power Equipments: Manufacturing Advanced Transformers For Modern Energy Needs")
.jpg "Overcoming the Hurdles of Scaling a Startup")
We use cookies to ensure you get the best experience on our website. Read more...
